Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin

Author:

Pusuluri Anusha123,Krishnan Vinu12,Wu Debra12,Shields C. Wyatt12,Wang Li W.124,Mitragotri Samir12

Affiliation:

1. John A. Paulson School of Engineering and Applied Sciences, Harvard University Cambridge MA 02138

2. Wyss Institute of Biologically Inspired Engineering, Harvard University Boston MA 02115

3. Department of Chemical EngineeringUniversity of California Santa Barbara CA 93106

4. Harvard–MIT Health Sciences and Technology ProgramInstitute for Medical Engineering and Science, Massachusetts Institute of Technology Cambridge MA 02139

Funder

Harvard School of Engineering and Applied Sciences

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Reference54 articles.

1. Cancer facts & figureures 2018;American Cancer Society;Am Cancer Soc,2018

2. Single agent versus combination chemotherapy for metastatic breast cancer ( Review );Carrick S;Cochrane Database Syst Rev,2009

3. Dose Escalation Methods in Phase I Cancer Clinical Trials

4. Synergy, additivism and antagonism in immunosuppression;Berenbaum MC;Clin Exp Immunol,1977

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3